Future changes to treatment strategies are likely to involve the earlier use of biological treatments ... Questionnaire Disability Index; RA: Rheumatoid arthritis; SF-36: Short Form-36; TSGS ...

Further research is needed to determine the risks and benefits of particular sequences of biologic therapies in patients with rheumatoid arthritis who require treatment change owing to inefficacy ...

Rheumatoid arthritis (RA) can be a challenging and ... Your doctor might encourage you to use a biologic along with other non-biologic treatments. For example, taking a biologic with: Ask your ...

Differences in rates of bDMARD treatment initiation among US veterans with RA living in rural vs urban areas cannot be fully explained by location.

Cerebras Systems has teamed with Mayo Clinic to create an AI genomic foundation model that predicts the best medical treatments.

University of Birmingham researchers have been awarded £3.5 million funding from Johnson & Johnson to investigate mechanisms of response and non-response to biologic and targeted synthetic therapies ...

Treatments for arthritis include medications ... and Skin Diseases (NIAMS): Osteoarthritis. NIAMS: Rheumatoid Arthritis.

Early treatment escalation to biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) following methotrexate (MTX) failure in new-onset rheumatoid arthritis (RA) does not ...

Upadacitinib demonstrated long-term efficacy for the treatment of ankylosing spondylitis among patients who failed to respond ...

University of Birmingham venture Dexter has demonstrated the power of its Dexter software platform in a study showing that ...

There is a bidirectional association between rheumatoid arthritis (RA ... In recent times, the newer group of biologics has increased treatment options. Science X Daily and the Weekly Email ...